Drug Shortage Report for TARO-ROSUVASTATIN

Last updated on 2020-03-30 History
Report ID 75286
Drug Identification Number 02382679
Brand name RAN-ROSUVASTATIN
Common or Proper name RAN-ROSUVASTATIN
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-31
Estimated end date 2020-03-27
Actual end date 2020-03-27
Shortage status Resolved
Updated date 2020-03-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v40 2020-03-30 French Compare
v39 2020-03-30 English Compare
v38 2020-03-20 French Compare
v37 2020-03-20 English Compare
v36 2020-02-24 French Compare
v35 2020-02-24 English Compare
v34 2020-02-02 French Compare
v33 2020-02-02 English Compare
v32 2020-01-28 French Compare
v31 2020-01-28 English Compare
v30 2020-01-04 French Compare
v29 2020-01-04 English Compare
v28 2019-12-13 French Compare
v27 2019-12-13 English Compare
v26 2019-11-26 French Compare
v25 2019-11-26 English Compare
v24 2019-11-01 French Compare
v23 2019-11-01 English Compare
v22 2019-10-21 French Compare
v21 2019-10-21 English Compare

Showing 1 to 20 of 40